CMKLR1 and stroke disorder: In ChemR23 KO mice, neurological impairment was further exacerbated as compared to the WT mice at Day 1, 3, 7, and 14 after MCAO, suggesting that ChemR23 deficiency exacerbates post-stroke neurological deficits.